A small new study suggests that people who’ve used GLP-1 drugs to reach a healthy weight can spread out their injections without regaining lost pounds.

The findings of two RCTs suggest estetrol has promise as an additional estrogen formulation option for postmenopausal women.

A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight ...

Your weekly horoscope is here to provide you with the insight and guidance you need to navigate the ups and downs of life.

The University of Denver is launching CEGAIA, an interdisciplinary hub integrating AI and ethics across teaching, research, ...

Gemini, expect a week of vibrant growth and social connections, with early joys at home. Midweek brings a surge in confidence ...

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, ...

The Phase 2a data1 from initial dosing cohorts marks the first robust demonstration of an oral OX2R agonist addressing wakefulness needs across NT1 patients, who lack endogenous orexin, and the ...

Some scientists argue that the link between increasing heat and adverse maternal outcomes is quietly becoming a public health ...

High-earning mothers carry the same mental load as lower-income moms. Money can't fix the invisible burden of household ...

POTTSTOWN — Join First Presbyterian Church of Pottstown, 750 N. Evans St., on All Saints’ Sunday, November 2, for Faith and Friendship at 9:15 am and worship at 10:30 am. The sacrament of the Lord’s ...

A new clinical trial has found that a once-weekly injection of eloralintide, a new experimental drug, led to weight loss of ...